ONCORAL PHARMA APS

Follow

Organization

Ballerup, OT, DK

Organizations

Please log in for detailed analytics

Patents Grantslast 30 patents

Information Patent Grant
Solid oral dosage form of irinotecan for the treatment of cancer
- Patent number 11,666,537
- Issue date Jun 6, 2023
- Oncoral Pharma ApS
- Bent Højgaard
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Solid oral dosage form of irinotecan for the treatment of cancer
- Patent number 11,419,825
- Issue date Aug 23, 2022
- ONCORAL PHARMA APS
- Bent Højgaard
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Solid oral dosage form of irinotecan for the treatment of cancer
- Patent number 10,143,657
- Issue date Dec 4, 2018
- Oncoral Pharma ApS
- Bent Højgaard
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
SOLID ORAL DOSAGE FORM OF IRINOTECAN FOR THE TREATMENT OF CANCER
- Publication number 20220354799
- Publication date Nov 10, 2022
- Oncoral Pharma ApS
- Bent Hojgaard
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SOLID ORAL DOSAGE FORM OF IRINOTECAN FOR THE TREATMENT OF CANCER
- Publication number 20180369153
- Publication date Dec 27, 2018
- Oncoral Pharma ApS
- Bent Hojgaard
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SOLID ORAL DOSAGE FORM OF IRINOTECAN FOR THE TREATMENT OF CANCER
- Publication number 20160331692
- Publication date Nov 17, 2016
- ONCORAL PHARMA APS
- Bent Højgaard
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Trademarklast 30 trademarks